84 filings
6-K
MDXH
MDxHealth SA
16 May 24
Report of Foreign Private Issuer
8:14am
6-K
MDXH
MDxHealth SA
6 May 24
Report of Foreign Private Issuer
8:00am
6-K
MDXH
MDxHealth SA
1 May 24
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
4:03pm
6-K
MDXH
MDxHealth SA
1 May 24
Unaudited Condensed Consolidated Statement of Profit or Loss
8:54am
424B5
MDXH
MDxHealth SA
30 Apr 24
Prospectus supplement for primary offering
5:20pm
6-K
xytd2g4tfzsr2dzzu
12 Mar 24
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
5:01pm
6-K
u0t2eadrp1y1fd6 bw
6 Mar 24
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
5:04pm
6-K
3atnpx d8s
16 Feb 24
Mdxhealth Announces Resignation of Board Member
4:05pm
6-K
8b71yi fiuvl10q
8 Jan 24
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues
4:39pm
6-K
ys1g38q
19 Dec 23
MDxHealth Announces Completion of Transition to Single Listing on Nasdaq
4:25pm
6-K
mori9ol421w82w0
27 Nov 23
MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq
4:01pm
8-A12B/A
mz0dvcapo 8pf1hrzld
24 Nov 23
Registration of securities on exchange (amended)
1:25pm
25-NSE
neeyv7
24 Nov 23
Exchange delisting
1:24pm
6-K
1ofjbk
15 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
esqvn qqryhfb5
13 Nov 23
MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights
5:06pm
6-K
n63jg 8j8dv2tkur
8 Nov 23
Report of Foreign Private Issuer
4:23pm
6-K
bl5j5
8 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
9nx21u8
6 Nov 23
Report of Foreign Private Issuer
8:00am
6-K
irakz 5rse9bzdiz
23 Oct 23
Report of Foreign Private Issuer
5:09pm